Publications by authors named "Richard Pollock"

Claim this Profile
E
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK).
Zobair M Younossi, James M Paik, Linda Henry, Richard F Pollock, Maria Stepanova

Ann Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Swedish cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in the treatment of iron deficiency anemia in patients with inflammatory bowel disease.
Stefan C Lindgren, Hans Strid, Henrik Hjortswang, Bardh Manxhuka, Neesha Nanu, Richard F Pollock

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility of Real-Time Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Sweden.
Johan Jendle, Sabrina Ilham, Hamza Alshannaq, Jessica Y Matuoka, Richard F Pollock

Diabetes Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of Subcutaneous Methotrexate in the Treatment of Patients with Rheumatoid Arthritis in the UK.
Matthew Tucker, Johannes Pöhlmann, Kristin Grabe-Heyne, Annelie Wagner, Anja Rasch, Richard F Pollock

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Cost-Effectiveness of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in the Treatment of Patients with Insulin-Treated Type 2 Diabetes in Australia.
Hamza Alshannaq, David Simmons, Jessica Y Matuoka, Richard F Pollock, Matthew Tucker

Adv Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of the MiniMed 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People with Type 1 Diabetes in France.
Helene Hanaire, Asli Zeynep Ozdemir Saltik, Richard F Pollock, Neesha Nanu, Clea Sambuc

Diabetes Technol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review and meta-analysis of real-world evidence on commercially available automated insulin delivery systems in people with type 1 diabetes.
Johannes Pöhlmann, Jayne Smith-Palmer, Erik H Serné, Anna-Kaisa Tuomaala, Johan Jendle, Richard F Pollock

Diabetes Obes Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in People With Type 2 Diabetes Treated With Non-Intensive Insulin Therapy in South Korea.
Ji Yoon Kim, Sabrina Ilham, Hamza Alshannaq, Richard F Pollock, Martin Field

J Diabetes Sci Technol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Time-in-Range in Type 1 Diabetes: Projecting the Clinical and Cost Implications of Automated Insulin Delivery.
Sufyan Hussain, Asli Zeynep Ozdemir Saltik, Jessica J Yu, Simona de Portu, Richard F Pollock

Diabetes Technol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time continuous glucose monitoring vs self-monitoring of blood glucose in distinct multi-ethnic cohorts of patients living with insulin-treated type 2 diabetes in the United States: A cost-utility analysis from a Medicare perspective.
Hamza Alshannaq, Jessica Matuoka, Richard F Pollock, Waqas Ahmed, Peter Lynch

J Manag Care Spec Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point of Care Nucleic Acid Testing for Influenza-Like Illness: A Cost-Consequence Analysis for High-Risk Patients in Primary Care in Germany.
Johannes Pöhlmann, Anika Joecker, Tanja Wittki, Tray Brown, Richard F Pollock

Adv Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.
Manuel De la Torre-Aláez, Ana Matilla, María Varela, Mercedes Iñarrairaegui, María Reig, Richard F Pollock

J Patient Rep Outcomes· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of adverse events and quality of life in patients with unresectable hepatocellular carcinoma.
Ion Agirrezabal, Richard F Pollock, Phuong Lien Carion, Suki Shergill, Victoria K Brennan

Qual Life Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Ting Zhao, Michelle Tew, Talitha Feenstra, Pieter van Baal, Michael Willis, Richard F Pollock

Appl Health Econ Health Policy· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China.
Fengkui Zhang, Aizong Shen, Waqas Ahmed, Richard F Pollock

Adv Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility of Real-Time Continuous Glucose Monitoring versus Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes in Spain.
Juan Francisco Merino-Torres, Sabrina Ilham, Hamza Alshannaq, Richard F Pollock, Waqas Ahmed

Clinicoecon Outcomes Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin.
Ji Yoon Kim, Sabrina Ilham, Hamza Alshannaq, Richard F Pollock, Waqas Ahmed

J Med Econ· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden.
Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, Andreas Kallsoy Slættanes, Mikael Svärd, Richard F Pollock

Clinicoecon Outcomes Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review of Studies Reporting Measures of Functional Outcome or Quality of Life in People with Negative Symptoms of Schizophrenia.
Dusica Hadzi Boskovic, Jayne Smith-Palmer, Johannes Pöhlmann, Richard F Pollock, Steve Hwang

Patient Relat Outcome Meas· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Hamza Alshannaq, Richard F Pollock, Michael Joubert, Waqas Ahmed, Gregory J Norman

J Comp Eff Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England.
Tariq H Iqbal, Nicholas Kennedy, Anjan Dhar, Waqas Ahmed, Richard F Pollock

J Med Econ· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.
Johannes Pöhlmann, Michael Weller, Andrea Marcellusi, Kristin Grabe-Heyne, Lucia Krott-Coi, Richard F Pollock

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO emissions in Sweden.
Lars-Olaf Cardell, Thomas Sterner, Waqas Ahmed, Andreas Kallsoy Slættanes, Mikael Svärd, Richard F Pollock

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.
Johan Jendle, Maria Ida Buompensiere, Asli Zeynep Ozdemir Saltik, Simona de Portu, Jayne Smith-Palmer, Richard F Pollock

Diabetes Technol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China.
Shanlian Hu, Depei Wu, Jing Wu, Yabing Zhang, Mette Bøgelund, Richard F Pollock

Patient Relat Outcome Meas· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis